Lifecore Biomedical P/E Ratio

Lifecore Biomedical (LFCR) currently reports a P/E ratio of -3.75. That is below the Materials sector average of 24.92. Use the charts on this page to explore Lifecore Biomedical's P/E ratio history and peer comparisons.

Lifecore Biomedical's P/E ratio of -3.75 is lower than the Materials sector average of 24.92. That is roughly 115.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates Lifecore Biomedical's market price to a fundamental measure such as earnings, sales, or book value. At -3.75, LFCR can look expensive or cheap only in context — versus its own history, growth rate, and Materials peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of -3.75, then check the historical chart for trend and the peer comparison chart for relative positioning. The Materials average is 24.92. From there, open related valuation or income-statement pages for Lifecore Biomedical, and consider following LFCR for alerts when major investors trade the stock.

Lifecore Biomedical is classified in the Materials sector. On P/E ratio, it currently shows -3.75 versus a sector average near 24.92. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Materials are usually more informative than comparing LFCR with unrelated industries.